The factors related to the poor ADL in the patients with osteoporotic vertebral fracture after instrumentation surgery.


Journal

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society
ISSN: 1432-0932
Titre abrégé: Eur Spine J
Pays: Germany
ID NLM: 9301980

Informations de publication

Date de publication:
07 2020
Historique:
received: 21 01 2019
accepted: 31 07 2019
revised: 02 06 2019
pubmed: 12 8 2019
medline: 17 6 2021
entrez: 12 8 2019
Statut: ppublish

Résumé

Osteoporotic vertebral fracture (OVF) with nonunion or neurological deficit may be a candidate for surgical treatment. However, some patients do not show improvement as expected. Therefore, we conducted a nationwide multicenter study to determine the predictors for postoperative poor activity of daily living (ADL) in patients with OVF. We retrospectively reviewed the case histories of 309 patients with OVF who underwent surgery. To determine the factors predicting postoperative poor ADL, uni- and multivariate statistical analyses were performed. The frequency of poor ADL at final follow-up period was 9.1%. In univariate analysis, preoperative neurological deficit (OR, 4.1; 95% CI, 1.8-10.3; P < 0.001), perioperative complication (OR, 3.4; P = 0.006), absence of preoperative bone-modifying agent (BMA) administration (OR, 2.7; P = 0.03), and absence of postoperative recombinant human parathyroid hormone (rPTH) administration (OR, 3.9; P = 0.006) were significantly associated. In multivariate analysis, preoperative neurological deficit (OR, 4.6; P < 0.001), perioperative complication (OR, 3.4; P = 0.01), and absence of postoperative rPTH administration (OR, 3.9; P = 0.02) showed statistical significance. Preoperative neurological deficit, perioperative complication, and absence of postoperative rPTH administration were considered as predictors for postoperative poor ADL in patients with OVF. Neurological deficits and complications are often inevitable factors; therefore, rPTH is an important option for postoperative treatment for OVF. These slides can be retrieved under Electronic Supplementary Material.

Identifiants

pubmed: 31401687
doi: 10.1007/s00586-019-06092-0
pii: 10.1007/s00586-019-06092-0
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1597-1605

Auteurs

Kazuma Murata (K)

Department of Orthopedic Surgery, Tokyo Medical University, 6-7-1 Nishishinjuku, Shijjuku-ku, Tokyo, 160-0023, Japan. kaz.mur26@gmail.com.

Yuji Matsuoka (Y)

Department of Orthopedic Surgery, Tokyo Medical University, 6-7-1 Nishishinjuku, Shijjuku-ku, Tokyo, 160-0023, Japan.

Hirosuke Nishimura (H)

Department of Orthopedic Surgery, Tokyo Medical University, 6-7-1 Nishishinjuku, Shijjuku-ku, Tokyo, 160-0023, Japan.

Kenji Endo (K)

Department of Orthopedic Surgery, Tokyo Medical University, 6-7-1 Nishishinjuku, Shijjuku-ku, Tokyo, 160-0023, Japan.

Hidekazu Suzuki (H)

Department of Orthopedic Surgery, Tokyo Medical University, 6-7-1 Nishishinjuku, Shijjuku-ku, Tokyo, 160-0023, Japan.

Taichiro Takamatsu (T)

Department of Orthopedic Surgery, Tokyo Medical University, 6-7-1 Nishishinjuku, Shijjuku-ku, Tokyo, 160-0023, Japan.

Yasunobu Sawaji (Y)

Department of Orthopedic Surgery, Tokyo Medical University, 6-7-1 Nishishinjuku, Shijjuku-ku, Tokyo, 160-0023, Japan.

Takato Aihara (T)

Department of Orthopedic Surgery, Tokyo Medical University, 6-7-1 Nishishinjuku, Shijjuku-ku, Tokyo, 160-0023, Japan.

Takuya Kusakabe (T)

Department of Orthopedic Surgery, Tokyo Medical University, 6-7-1 Nishishinjuku, Shijjuku-ku, Tokyo, 160-0023, Japan.

Asato Maekawa (A)

Department of Orthopedic Surgery, Tokyo Medical University, 6-7-1 Nishishinjuku, Shijjuku-ku, Tokyo, 160-0023, Japan.

Kengo Yamamoto (K)

Department of Orthopedic Surgery, Tokyo Medical University, 6-7-1 Nishishinjuku, Shijjuku-ku, Tokyo, 160-0023, Japan.

Kei Watanabe (K)

Niigata University, 1-757 Asahimachidori, Chuo-ku, Niigata-shi, Niigata, 951-8510, Japan.

Takashi Kaito (T)

Osaka University, 2 Yamadaoka, Suita-shi, Osaka, 565-0871, Japan.

Hidetomi Terai (H)

Osaka City University, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan.

Koji Tamai (K)

Osaka City University, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan.

Atushi Tagami (A)

Nagasaki University, 1-7-1 Sakamoto, Nagasaki-shi, Nagasaki, 852-8501, Japan.

Toshitaka Yoshii (T)

Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan.

Katsumi Harimaya (K)

Kyusyu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka-shi, Fukuoka, 812-8582, Japan.

Kenichi Kawaguchi (K)

Kyusyu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka-shi, Fukuoka, 812-8582, Japan.

Atsushi Kimura (A)

Jichi Medical University, 3311-1 Yakushiji, Shimotsuke-shi, Tochigi, 329-0498, Japan.

Gen Inoue (G)

Kitasato University, 1-15-1 Kitasato, Minami-ku, Sagamihara-shi, Kanagawa, 252-0374, Japan.

Atsushi Nakano (A)

Osaka Medical College, 2-7 Daigakumachi, Tskatsuki-shi, Osaka, 569-0801, Japan.

Daisuke Sakai (D)

Tokai University, 143 Shimokasuya, Isehara-shi, Kanagawa, 259-1193, Japan.

Akihiko Hiyama (A)

Tokai University, 143 Shimokasuya, Isehara-shi, Kanagawa, 259-1193, Japan.

Shota Ikegami (S)

Shinshu University, 3-1-1 Asahi, Matsumoto-shi, Nagano, 390-8621, Japan.

Seiji Ohtori (S)

Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, 260-8670, Japan.

Takeo Furuya (T)

Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, 260-8670, Japan.

Sumihisa Orita (S)

Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, 260-8670, Japan.

Shiro Imagama (S)

Nagoya University, 65 Tsurumai-cho, Showa-ku, Nagoya-shi, Aichi, 466-8560, Japan.

Kazuyoshi Kobayashi (K)

Nagoya University, 65 Tsurumai-cho, Showa-ku, Nagoya-shi, Aichi, 466-8560, Japan.

Katsuhito Kiyasu (K)

Kochi University, 185-1 Kohasu, Okaho-cho, Nankoku-shi, Kochi, 783-8505, Japan.

Hideki Murakami (H)

Kanazawa University, 13-1 Takaramachi, Kanazawa-shi, Ishikawa, 920-0934, Japan.

Katsuhito Yoshioka (K)

Kanazawa University, 13-1 Takaramachi, Kanazawa-shi, Ishikawa, 920-0934, Japan.

Shoji Seki (S)

University of Toyama, 2630 Sugitani, Toyama-shi, Toyama, 930-0194, Japan.

Michio Hongo (M)

Akita University, 1-1-1 Hondo, Akita-shi, Akita, 010-8543, Japan.

Kenichiro Kakutani (K)

Kobe University, 7-5-1 Kusunoki-cho, Chuou-ku, Kobe-shi, Hyogo, 650-0017, Japan.

Takashi Yurube (T)

Kobe University, 7-5-1 Kusunoki-cho, Chuou-ku, Kobe-shi, Hyogo, 650-0017, Japan.

Yasuchika Aoki (Y)

Eastern Chiba Medical Center, 3-6-2 Okayamadai, Togane-shi, Chiba, 283-8686, Japan.

Hiroshi Uei (H)

Nihon University, 30-1 Oyaguchikamicho, Itabashi-ku, Tokyo, 173-8610, Japan.

Yasumitsu Ajiro (Y)

Nihon University, 30-1 Oyaguchikamicho, Itabashi-ku, Tokyo, 173-8610, Japan.

Masahiko Takahata (M)

Hokkaido University, Kita-15, Nishi-7, Kita-ku, Sapporo-shi, Hokkaido, 060-8683, Japan.

Hirooki Endo (H)

Iwate Medical University, 19-1 Uchimaru, Morioka-shi, Iwate, 020-8505, Japan.

Tetsuya Abe (T)

University of Tsukuba, 1-1-1 Tennodai, Tsukuba-shi, Ibaraki, 305-8577, Japan.

Kazuyoshi Nakanishi (K)

Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima City, Hiroshima, 734-8551, Japan.

Kota Watanabe (K)

Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.

Eijiro Okada (E)

Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.

Naobumi Hosogane (N)

Kyorin University, 6-20-2 Shinkawa, Mitaka-shi, Tokyo, 181-8611, Japan.

Haruki Funao (H)

International University of Health and Welfare, 1-4-3 Mita, Minato-ku, Tokyo, 108-8329, Japan.

Norihiro Isogai (N)

International University of Health and Welfare, 1-4-3 Mita, Minato-ku, Tokyo, 108-8329, Japan.

Ken Ishii (K)

International University of Health and Welfare, 1-4-3 Mita, Minato-ku, Tokyo, 108-8329, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH